Preferred Label : cabazitaxel;

MeSH note : an antineoplastic agent; structure in first source;

CISMeF synonym : jevtana;

MeSH synonym : kabazitaxel;

MeSH CAS label : 4-acetoxy-13-((3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-1-hydroxy-7,10-dimethoxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate;

Is substance : O;

UNII : 51F690397J;

InChIKey : BMQGVNUXMIRLCK-OAGWZNDDSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3471685/fr/cabazitaxel-sandoz-cabazitaxel-monohydrate-cancer-de-la-prostate
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
antineoplastic combined chemotherapy protocols
antineoplastic agents
adult
neoplasm metastasis
cabazitaxel
prednisone
prednisolone
infusions, intravenous
evaluation of the transparency committee
prostatic neoplasms, Castration-Resistant
cabazitaxel

---
https://www.has-sante.fr/jcms/p_3373583/fr/cabazitaxel-viatris-cabazitaxel
2022
false
false
false
France
antineoplastic combined chemotherapy protocols
insurance, health, reimbursement
treatment outcome
prostatic neoplasms, Castration-Resistant
antineoplastic agents
adult
prednisone
prednisolone
cabazitaxel
infusions, intravenous
Cabazitaxel/Prednisone Regimen
evaluation of the transparency committee
cabazitaxel

---
https://ansm.sante.fr/informations-de-securite/cabazitaxel-accord-60-mg-risque-derreurs-medicamenteuses-et-de-confusion-avec-jevtana-60-mg-1-5-ml
2021
false
false
false
France
French
pharmacovigilance note
cabazitaxel
medication errors
infusions, intravenous
wrong drug administered
taxoids

---
https://www.has-sante.fr/jcms/p_3291303/fr/cabazitaxel-zentiva-20-mg/ml-cabazitaxel
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
cabazitaxel
cabazitaxel
drug therapy, combination
adult
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
Cabazitaxel/Prednisone Regimen
infusions, intravenous
antineoplastic agents
evaluation of the transparency committee

---
https://www.ema.europa.eu/en/medicines/human/EPAR/cabazitaxel-accord
2020
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
cabazitaxel
drug approval
europe
cabazitaxel
cabazitaxel
antineoplastic agents
antineoplastic agents
neoplasm metastasis
prostatic neoplasms, Castration-Resistant
antineoplastic combined chemotherapy protocols
infusions, intravenous
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
taxoids
taxoids

---
https://www.has-sante.fr/jcms/p_3212155/fr/cabazitaxel-accord
2020
false
false
false
France
cabazitaxel
treatment outcome
insurance, health, reimbursement
infusions, intravenous
adult
drug therapy, combination
prostatic neoplasms, Castration-Resistant
prednisolone
prednisone
antineoplastic agents
evaluation of the transparency committee
cabazitaxel
taxoids

---
https://www.has-sante.fr/jcms/p_3203283/fr/cabazitaxel-ever-pharma
2020
false
false
false
France
cabazitaxel
drug therapy, combination
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Product containing only cabazitaxel in parenteral dose form (medicinal product form)
antineoplastic agents
adult
prostatic neoplasms, Castration-Resistant
neoplasm metastasis
evaluation of the transparency committee
cabazitaxel
taxoids

---
https://www.has-sante.fr/jcms/p_3196326/fr/cabazitaxel-reddy-pharma
2020
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
cabazitaxel
cabazitaxel
taxoids

---
https://www.has-sante.fr/jcms/p_3203280/fr/cabazitaxel-teva-sante
2020
false
false
false
France
antineoplastic agents
treatment outcome
insurance, health, reimbursement
drug therapy, combination
infusions, intravenous
Product containing only cabazitaxel in parenteral dose form (medicinal product form)
cabazitaxel
prostatic neoplasms, Castration-Resistant
adult
evaluation of the transparency committee
cabazitaxel
taxoids

---
https://www.has-sante.fr/portail/jcms/c_2893472/en/jevtana
2018
false
false
false
France
evaluation of the transparency committee
deposition, nos
dataset
cabazitaxel
cabazitaxel
dataset
taxoids

---
http://www.has-sante.fr/portail/jcms/c_1735878/fr/jevtana-xtandi-et-zytiga-cabazitaxel-enzalutamide-et-abiraterone-des-progres-therapeutiques-pour-certains-cancers-metastatiques-de-la-prostate-fiche-bum
2014
true
France
French
cabazitaxel
cabazitaxel
infusions, intravenous
neoplasm metastasis
prostatic neoplasms
antineoplastic agents
guidelines for drug use
administration, oral
enzalutamide
anti-androgens
androgen antagonists
antineoplastic agents, hormonal
abiraterone
steroid 17-alpha-hydroxylase
enzyme inhibitors
drug therapy, combination
survival analysis
phenylthiohydantoin
taxoids
Abiraterone Acetate

---
https://www.ema.europa.eu/medicines/human/EPAR/Jevtana
2012
United Kingdom
English
French
syndication feed
taxoids
taxoids
infusions, intravenous
prostatic neoplasms
neoplasm metastasis
drug approval
treatment outcome
adult
aged
drug interactions
antineoplastic agents
antineoplastic agents
fertility
drug evaluation, preclinical
cabazitaxel
cabazitaxel
cabazitaxel
drug evaluation
package leaflet
summary of product characteristics

---
http://www.has-sante.fr/portail/jcms/c_1340463/jevtana
http://www.has-sante.fr/portail/jcms/c_1341945/jevtana17102012-avis-ct-12292
2012
France
French
cabazitaxel
cabazitaxel
cabazitaxel
treatment outcome
prostatic neoplasms
neoplasm metastasis
drug resistance, neoplasm
infusions, intravenous
antineoplastic agents
antineoplastic agents
taxoids
taxoids
survival analysis
clinical trials, phase iii as topic
survival
antineoplastic combined chemotherapy protocols
prednisone
prednisolone
evaluation of the transparency committee
randomized controlled trials as topic

---
http://www.has-sante.fr/portail/jcms/c_1357758/jevtana-et-zytiga-un-progres-therapeutique-modere-pour-certains-cancers-metastatiques-de-la-prostate-fiche-bum
http://www.has-sante.fr/portail/jcms/c_1357763/bum-jevtana-zytiga
2012
false
France
French
Abiraterone Acetate
prostatic neoplasms
neoplasm metastasis
evaluation of the transparency committee
guidelines for drug use
taxoids
antineoplastic agents
cabazitaxel

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailOne.php?lang=fr&linkID=SBD00081
2011
false
false
false
Canada
drug information
cabazitaxel

---
http://www.has-sante.fr/portail/jcms/c_1118594/jevtana
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/jevtana_19-10-2011_avis_ct-10702.pdf
http://www.has-sante.fr/portail/jcms/c_1339066/jevtana-ct-10702-version-anglaise
2011
France
French
English
evaluation of the transparency committee
infusions, intravenous
antineoplastic agents
taxoids
prostatic neoplasms
neoplasm metastasis
treatment outcome
survival analysis
cabazitaxel
cabazitaxel

---
http://www.has-sante.fr/portail/jcms/c_1230772/jevtana-cabazitaxel-taxane
2011
France
French
guidelines for drug use
evaluation of the transparency committee
cabazitaxel
prostatic neoplasms
drug therapy, combination
neoplasm metastasis
taxoids
cabazitaxel
antineoplastic agents
infusions, intravenous
treatment outcome
clinical trials, phase iii as topic
randomized controlled trials as topic
survival analysis
disease-free survival
Prostate-Specific antigen
drug resistance, neoplasm
comparative study

---
Nous contacter.
25/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.